APA

Aydemirli M. D., Kapiteijn E., Ferrier K. R. M., Ottevanger P. B., Links T. P., van der Horst-Schrivers A. N. A., Broekman K. E., Groenwold R. H. H. & Zwaveling J. (20200316). Effectiveness and toxicity of lenvatinib in refractory thyroid cancer: Dutch real-life data. : European journal of endocrinology.

Chicago

Aydemirli M D, Kapiteijn E, Ferrier K R M, Ottevanger P B, Links T P, van der Horst-Schrivers A N A, Broekman K E, Groenwold R H H and Zwaveling J. 20200316. Effectiveness and toxicity of lenvatinib in refractory thyroid cancer: Dutch real-life data. : European journal of endocrinology.

Harvard

Aydemirli M. D., Kapiteijn E., Ferrier K. R. M., Ottevanger P. B., Links T. P., van der Horst-Schrivers A. N. A., Broekman K. E., Groenwold R. H. H. and Zwaveling J. (20200316). Effectiveness and toxicity of lenvatinib in refractory thyroid cancer: Dutch real-life data. : European journal of endocrinology.

MLA

Aydemirli M D, Kapiteijn E, Ferrier K R M, Ottevanger P B, Links T P, van der Horst-Schrivers A N A, Broekman K E, Groenwold R H H and Zwaveling J. Effectiveness and toxicity of lenvatinib in refractory thyroid cancer: Dutch real-life data. : European journal of endocrinology. 20200316.